
Velsera is a global precision medicine technology company that accelerates the discovery, development, and delivery of precision medicine through integrated AI-enhanced software and expert services. The company offers a suite of cutting-edge platforms including the Seven Bridges Trusted Research Environment for bioinformatic analysis, the award-winning GRAF reference genome tool, the ARIA data harmonization and secure sharing platform, the Clinical Genomics Workspace for tertiary analysis and reporting, and an IVD-grade variant interpretation Knowledgebase. Velsera serves biotech and pharmaceutical companies, clinical diagnostic labs, NGS assay and equipment manufacturers, and non-profits and government agencies, helping them unlock and harmonize clinical and multi-omic data to accelerate research breakthroughs and scale genetic testing. With over 80 active clinical NGS lab customers, more than 250,000 NGS samples sequenced, and 18,000 researchers using its platforms, Velsera is positioned as one of the largest omics analytics providers, supporting top pharmaceutical companies and advancing precision medicine globally.

Velsera is a global precision medicine technology company that accelerates the discovery, development, and delivery of precision medicine through integrated AI-enhanced software and expert services. The company offers a suite of cutting-edge platforms including the Seven Bridges Trusted Research Environment for bioinformatic analysis, the award-winning GRAF reference genome tool, the ARIA data harmonization and secure sharing platform, the Clinical Genomics Workspace for tertiary analysis and reporting, and an IVD-grade variant interpretation Knowledgebase. Velsera serves biotech and pharmaceutical companies, clinical diagnostic labs, NGS assay and equipment manufacturers, and non-profits and government agencies, helping them unlock and harmonize clinical and multi-omic data to accelerate research breakthroughs and scale genetic testing. With over 80 active clinical NGS lab customers, more than 250,000 NGS samples sequenced, and 18,000 researchers using its platforms, Velsera is positioned as one of the largest omics analytics providers, supporting top pharmaceutical companies and advancing precision medicine globally.
GRC Expert
Descriptio
nAbout Velser
aMedicine moves too slow. At Velsera, we are changing that
.Velsera was formed in 2023 through the shared vision of Seven Bridges and Pierian, with a mission to accelerate the discovery, development, and delivery of life-changing insights
.Velsera provides software and professional services for
nWith our headquarters in Boston, MA, we are growing and expanding our teams located in different countries
**!
What will you d**
o?Compliance & Governan
**A.
Requireme**
ntsWhat do you bring to the tab
le?· Experien
r).
Soft Sk
ity.Bene
e...